Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in sub-saharan Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 5, 2008, Pages 523-531

  Dabis, Francois ^a,b   Mbori Ngacha, Dorothy ^b   Arrive, Elise ^b   Kyabayinze, Daniel ^b   Marquis, Benoit ^b   Namale, Leticia ^b   Olet, Susan ^b   Tumwesigye, Nathan ^b   Azondekon, Alain ^b   Kaboré, Alice Zougrana ^c   Boulle, Andrew ^d   Coetzee, David ^d   Violari, Avi ^e   Jokhan, Rikash ^e   Ondoa Onama, Christine ^f   Abrams, Elain ^g   Sunioh, Frida ^h   Sy, Haby Signaté ⁱ   Ndiaye, Fatou Ly ⁱ   Massawe, Higgins ^j   Massawe, Augustin ^j   Kiwanuka, Julius ^k   Chipepo, Kankasa ^l   Mwiya, Mwiya ^l   Renner, Lorna ^m   Goka, Bamenla ^m   Wemin, Louise ⁿ   Pascoe, Margaret ^o   Nanyonga, Maria ^p   Sylla, Mariam ^q   Dicko Traoré, Fatoumata ^q   Uwurukundo, Marie Claude ^r   Cotton, Mark ^s   Rabie, Helena ^s   Prozesky, Hans ^s   Edson, Clair ^s   Weber, Heinrich ^s   Madide, Ayanda ^s   Paterson, Mark ^t   Muganga, Narcisse ^u   Fassinou, Patricia ^v   Nimbona, Pelagie ^w   Kariyo, Pierre ^x   Weigel, Ralf ^y   Jones, Sarah Rowland ^z   Aveika, Akum ^z   Meade, Tim ^aa   Luo, Chewe ^ab   Abrams, Elaine ^ac   Newell, Marie Louise ^ad   Kieffer, Mary Pat ^ae   Egger, Matthias ^af   Miotti, Paolo ^ag   Nduati, Ruth ^ae   Leroy, Valériane ^ah   more..

^a INSERM   (France)

^b Service d hépato gastroentérologie de l Hôpital d Instruction des Armées de Cotonou   (Benin)

^c Charles de Gaulle (CDG) Hospital   (Burkina Faso)

^d Khayelitsha Community Health Centre   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f Arua Regional Referral Hospital   (Uganda)

^g 12 MTCT Plus Sites   (United States)

^h Provincial Hospital   (Cameroon)

ⁱ Hopital d'Enfants Albert Royer Dakar   (Senegal)

^j MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^k MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^l UNIVERSITY TEACHING HOSPITAL   (Zambia)

^m Korle Bu Hospital   (Ghana)

ⁿ CEPREF Enfants   (Côte d’Ivoire)

^o Connaught Clinic ^*  (Zimbabwe)

^p Nsambya Hospital   (Uganda)

^q HÔPITAL GABRIEL TOURÉ   (Mali)

^r CHU Butare   (Rwanda)

^s STELLENBOSCH UNIVERSITY   (South Africa)

^t Provincial Hospital of Mutare   (Zimbabwe)

^u CHU Kigali   (Rwanda)

^v CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^w Association Nationale de Soutien Aux Séropositifs ANSS   (Burundi)

^x Central Hospital   (Burundi)

^y LIGHTHOUSE TRUST   (Malawi)

^z MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^aa CorpMed Clinic ^*  (Zambia)

^ab United Nations Childrens Fund   (South Africa)

^ac Och Spine at New York Presbyterian Hospitals   (United States)

^ad Ghent Group and European Collaborative Study   (South Africa)

^ae USAID ^*

^af UNIVERSITY OF BERN   (Switzerland)

^ag NATIONAL INSTITUTES OF HEALTH   (United States)

^ah ISPED Bordeaux II   (France)

more..

Author keywords

Antiretroviral treatment; Children; Death; HIV; Loss to follow up; Sub Saharan Africa

Indexed keywords

COTRIMOXAZOLE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA SOUTH OF THE SAHARA; ANEMIA; ARTICLE; CAUSE OF DEATH; CHILD; CHILD DEATH; CHILDHOOD MORTALITY; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENETIC HETEROGENEITY; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS; UNDERWEIGHT; ADOLESCENT; MORTALITY; PATIENT COMPLIANCE; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PATIENT COMPLIANCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 62749166480     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31818aadce     Document Type: Article

References (35)

1. WHO. Towards Universal Access. Scaling up priority HIV/AIDS interventions in the health sector. Available at: http://www.who.int/hiv/ pub/towards-universal-access-report-2008.pdf. Accessed July 7, 2008.
2. UNAIDS. 2007 AIDS epidemic update. Available at: http://data. unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf. Accessed July 7, 2008.
3. WHO. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Available at: http:// www.who.int/hiv/pub/guidelines/art/en/index.html. Accessed July 7, 2008.
4. WHO. Children and AIDS, a stocktaking report. Available at: http:// www.who.int/hiv/paediatric/stocktakingreport.pdf. Accessed July 7, 2008.
5. Eley B, Davies MA, Apolles P, et al. Antiretroviral treatment for children. S Afr Med J. 2006;96:988-993.
6. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18: 1905-1913.
7. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr. 2006;43:418-425.
8. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960.
9. Rouet F, Fassinou P, Inwoley A, et al. Long-term survival and immunovirological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS. 2006;20:2315-2319.
10. Kariyo P, Mbuzenakamwe M, Baramperanye E, et al. Antiretroviral therapy in a hundred Burundian children with AIDS. Paper presented at: XVI International AIDS Conference; August 13-18, 2006; Toronto, Ontario. Abstract MOPE0208.
11. Mbewe M, Bolton C, Levy J, et al. Children enrolled in a public HIV care and treatment program in Lusaka, Zambia: rapid scale-up and first-year clinical outcomes. Paper presented at: XVI International AIDS Conference; August 13-18, 2006; Toronto, Ontario. Abstract MOAB0201.
12. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899.
13. Mbori-Ngacha D, Kyabayinze D, Arrivé E, et al. Paediatric ART in subSaharan Africa: program characteristics in the multi-center international KIDS-ART-LINC collaboration. Paper presented at: XVI International AIDS Conference; August 13-18, 2006; Toronto, Ontario. Abstract MOPE0257.
14. Arrivé E, Kyabayinze D, Marquis B, et al. Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDSART-LINC) collaboration. Int J Epidemiol. 2007;37:474-480.
15. DAIDS. Table for grading the severity of adult and pediatric adverse events. Available at: http://www3.niaid.nih.gov/research/resources/ DAIDSClinRsrch/PDF/Safety/DAIDSAEGradingTable.pdf. Accessed July 7, 2008.
16. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
17. Nardi A, Schemper M. Comparing Cox and parametric models in clinical studies. Stat Med. 2003;22:3597-3610.
18. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HW-1-infected patients in the first year of antiretroviral therapy: comparison between lowincome and high-income countries. Lancet. 2006;367:817-824.
19. George E, Noel F, Bois G, et al. Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis. 2007;195:1411-1418.
20. Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21:1805-1810.
21. Jones SA, Sherman GG, Varga CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa. AIDS Care. 2005;17:466-470.
22. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health. 2005;10:1242-1250.
23. Violari A, Cotton M, Gibb D, et al. Antiretroviral therapy initiated before 12 weeks of age reduces early mortality in young HIV-infected infants: evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. Paper presented at: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia. 2007. Abstract WESS103.
24. Diack MA, Signate Sy H, Diagne Gueye NR, et al. Epidemiological and clinical aspects of paediatric HIV infections in Albert-Royer Paediatric Hospital (Dakar, Senegal) [in French]. Arch Pediatr. 2005;12:404-409.
25. Puthanakit T, Oberdorfer A, Akarathum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailands National Access to Antiretroviral Program. Clin Infect Dis. 2005;41: 100-107.
26. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZuluNatal, South Africa. BMC Pediatr. 2007;7:13.
27. O'Brien DP, Sauvageot D, Olson D, et al. Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clin Infect Dis. 2007;44:1245-1248.
28. van Kooten Niekerk NK, Knies MM, Howard J, et al. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr. 2006;52:3-11.
29. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493-1499.
30. Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIVinfected patients from sub-Saharan Africa. J Acquir Immune Defic Syndr. 2004;35:320-323.
31. Brinkhof MWG, Dabis F, Myer L, et al. Early loss to program in HIVinfected patients starting potent antiretroviral therapy in lower-income countries. Bull World Health Organ. 2008;86:559-567.
32. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364:1865-1871.
33. Hesseling AC, Westra AE, Werschkull H, et al. Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child. 2005;90: 1171-1174.
34. Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med. 2007; 356:135-147.
35. Sethi AK, Celentano DD, Gange SJ, et al. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37:1112-1118.